Impact Biomedical IBO
NYSE IBO
$5.14 +0.35 (+7.31%)
At close: Nov 13, 2026 · 4:00 PM EST

Impact Biomedical (IBO) Price to Earnings (2024 - 2026)

Updated

Impact Biomedical's Price to Earnings came in at 29.38 for Q3 2026, down 53.3% from the prior quarter.

Analysis

Impact Biomedical (IBO) Price to Earnings (2024 - 2026) Analysis & Trends

  • The Q3 2026 figure represents the lowest quarterly Price to Earnings since Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Impact Biomedical 43.92 Mn 47.11 Mn 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 29.38
Jun 30, 2026 62.86
Sep 30, 2024 19.82
API Access

Impact Biomedical Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=IBO&period=max&api_key=YOUR_API_KEY